EUVIMEDEUVIMED entdecken
Open Access

Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance Dialysis

Leila R Zelnick iD, Subbulaxmi Trikudanathan iD, Yoshio N Hall, Ernest Ayers, Lisa Anderson, Nathaniel Ashford, Evelin Jones, Andrea C Rivas-Nieto, Simon Hsu, Kuanysh Kabytaev, Zhuo Wang, Andrew N Hoofnagle und 2 weitere

Diabetes Care · 2026

DOI: 10.2337/dc25-2952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2026. Verfasst von Leila R Zelnick und 13 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, WA. Hauptthemen laut MEDLINE: Renal Dialysis, Biomarkers, Blood Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Accurate assessment of glycemia in patients treated with maintenance dialysis is imperative and hampered by known biases of glycated hemoglobin (HbA1c) in kidney failure (KF). This study evaluated the accuracy, variability, and covariate bias of three glycemic biomarkers compared with glycemia measured by continuous glucose monitor (CGM) among people with and without diabetes treated with maintenance dialysis. RESEARCH DESIGN AND METHODS In a prospective community-based cohort study, 251 participants treated with maintenance dialysis wore a Dexcom G6 Pro CGM for 10 days. We compared correlations of HbA1c, glycated albumin (GA), and fructosamine with CGM-derived mean glycemia and examined sources of bias. RESULTS Participants (43% women; 63% with diabetes) had a median of 9.3 (interquartile range 8.5–9.4) valid days of CGM data. Mean (SD) HbA1c, GA, fructosamine, and mean CGM glucose were 6.2% (1.4%), 19.6% (6.3%), 351 (99) µmol/L, and 170 (63) mg/dL, respectively. HbA1c, GA, and fructosamine all strongly correlated with mean CGM blood glucose, with HbA1c and GA more correlated than fructosamine (overall, r = 0.85, r = 0.87, and r = 0.70, respectively; in diabetes, r = 0.84, r = 0.84, and r = 0.64, respectively). Compared with mean CGM glucose, HbA1c was significantly biased by erythropoiesis-stimulating agent dose, BMI, hemoglobin, and serum albumin; GA and fructosamine were biased by dialysis modality and vintage, residual kidney function, and BMI. CONCLUSIONS HbA1c and GA were strongly correlated with mean CGM blood glucose, but all biomarkers had substantial bias by relevant clinical characteristics. HbA1c and GA may be useful assessments of average glycemia in patients treated with maintenance dialysis, if bias can be adequately addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisBiomarkersBlood GlucoseHumansFemaleGlycated HemoglobinFructosamineGlycated Serum AlbuminSerum AlbuminGlycation End Products, AdvancedContinuous Glucose MonitoringMiddle AgedMaleAgedProspective Studies

Substanzen

Glycated HemoglobinFructosamineGlycated Serum AlbuminSerum AlbuminGlycation End Products, AdvancedBiomarkersBlood Glucose

Autor:innen und Institutionen

  • Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, WA.
  • Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA.
  • Veterans Affairs Puget Sound Health Care System, Seattle, WA.
  • Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.

ORCID-Profile: Leila R Zelnick, Subbulaxmi Trikudanathan, Irl B Hirsch

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Zelnick, L. R., Trikudanathan, S., Hall, Y. N., Ayers, E., Anderson, L., Ashford, N., Jones, E., Rivas-Nieto, A. C., Hsu, S., Kabytaev, K., Wang, Z., Hoofnagle, A. N., Hirsch, I. B., & de Boer, I. H. (2026). Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance Dialysis. Diabetes Care. https://doi.org/10.2337/dc25-2952

Vancouver

Zelnick LR, Trikudanathan S, Hall YN, Ayers E, Anderson L, Ashford N, et al. Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance Dialysis. Diabetes Care. 2026. doi:10.2337/dc25-2952

BibTeX
@article{Zelnick2026,
  author = {Zelnick, Leila R and Trikudanathan, Subbulaxmi and Hall, Yoshio N and Ayers, Ernest and Anderson, Lisa and Ashford, Nathaniel and Jones, Evelin and Rivas-Nieto, Andrea C and Hsu, Simon and Kabytaev, Kuanysh and Wang, Zhuo and Hoofnagle, Andrew N and Hirsch, Irl B and de Boer, Ian H},
  title = {Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance Dialysis},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc25-2952}
}
Kostenlos starten →